Literature DB >> 6693298

Characterization of a murine monoclonal antibody specific for human early lymphohemopoietic cells.

F Malavasi, F Caligaris-Cappio, C Milanese, P Dellabona, P Richiardi, A O Carbonara.   

Abstract

This paper summarizes the results of the characterization of A10, a murine monoclonal antibody which recognizes an epitope not restricted to cells of a definite lineage, but which seems to be specific for an early differentiation antigen present on precursors of circulating T and B cells. The structure recognized by the A10 monoclonal antibody, although strikingly structurally similar to the HLA-A,B,C complex, is immunologically different both from histocompatibility antigens and from beta 2 microglobulin. Furthermore, the distribution of the A10 antigen is analyzed in different cell and tissue samples, both in health and disease conditions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6693298     DOI: 10.1016/0198-8859(84)90003-x

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  16 in total

1.  Purification and biochemical characterization of a 65-kilodalton mannoprotein (MP65), a main target of anti-Candida cell-mediated immune responses in humans.

Authors:  M J Gomez; A Torosantucci; S Arancia; B Maras; L Parisi; A Cassone
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Functional and molecular characterization by the CB04 monoclonal antibody of a cell surface structure exerting C3-complement receptor activity.

Authors:  F Malavasi; A Funaro; G Bellone; F Caligaris-Cappio; E Berti; C Tetta; P Dellabona; S DeMaria; M Campogrande; A P Cappa
Journal:  J Clin Immunol       Date:  1985-11       Impact factor: 8.317

3.  Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytes.

Authors:  F Malavasi; C Tetta; A Funaro; G Bellone; E Ferrero; A C Franzone; P Dellabona; R Rusci; L Matera; G Camussi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

4.  Interleukin-15 activates proinflammatory and antimicrobial functions in polymorphonuclear cells.

Authors:  T Musso; L Calosso; M Zucca; M Millesimo; M Puliti; S Bulfone-Paus; C Merlino; D Savoia; R Cavallo; A N Ponzi; R Badolato
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

Review 5.  CD38 autoimmunity: recent advances and relevance to human diabetes.

Authors:  A Antonelli; E Ferrannini
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

6.  Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myeloma.

Authors:  Abdullah S Al Saleh; M Hasib Sidiqi; Morie A Gertz; Eli Muchtar; Martha Q Lacy; Rahma M Warsame; Wilson I Gonsalves; Taxiarchis V Kourelis; William J Hogan; Suzanne R Hayman; Prashant Kapoor; Francis K Buadi; Angela Dispenzieri; David Dingli; Shaji K Kumar
Journal:  Am J Hematol       Date:  2019-10-21       Impact factor: 10.047

7.  Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.

Authors:  R Foa; N Migone; M Saitta; M T Fierro; M C Giubellino; P Lusso; L Cordero di Montezemolo; R Miniero; F Lauria
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

8.  CD38 and CD157 ectoenzymes mark cell subsets in the human corneal limbus.

Authors:  Alberto L Horenstein; Federico Sizzano; Riccardo Lusso; Federico Genzano Besso; Enza Ferrero; Silvia Deaglio; Franco Corno; Fabio Malavasi
Journal:  Mol Med       Date:  2008-11-19       Impact factor: 6.354

9.  Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.

Authors:  F Caligaris-Cappio; L Bergui; L Tesio; G Pizzolo; F Malavasi; M Chilosi; D Campana; B van Camp; G Janossy
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

10.  NAD-dependent inhibition of the NAD-glycohydrolase activity in A549 cells.

Authors:  Enrico Balducci; Luigi G Micossi
Journal:  Mol Cell Biochem       Date:  2002-04       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.